about
The Regulatory Roles of MicroRNAs in Bone Remodeling and Perspectives as Biomarkers in OsteoporosisIdentifying individuals at risk for fracture in GuatemalaPrediction of femoral strength using 3D finite element models reconstructed from DXA images: validation against experiments.Assessing fracture risk in early stage breast cancer patients treated with aromatase-inhibitors: An enhanced screening approach incorporating trabecular bone scoreSelf-report of one-year fracture incidence and osteoporosis prevalence in a community cohort of canadians with spinal cord injury.Quantitative imaging methods in osteoporosis.Fragility fracture: recent developments in risk assessment.Recommendations for Diagnosis and Management of Osteoporosis in COPD Men.A FRAX Experience in Korea: Fracture Risk Probabilities with a Country-specific Versus a Surrogate Model.Prediction of fracture risk in men: a cohort study.FRAX: Facts and Fantasy.Italian association of clinical endocrinologists (AME) position statement: drug therapy of osteoporosis.Technologies for assessment of bone reflecting bone strength and bone mineral density in elderly women: an updateFracture risk assessment: state of the art, methodologically unsound, or poorly reported?Rationale, design and clinical performance of the mechanical response tissue analyser: a non-invasive technology for measurement of long bone bending stiffness.What's in a name revisited: should osteoporosis and sarcopenia be considered components of "dysmobility syndrome?".A biomechanical sorting of clinical risk factors affecting osteoporotic hip fracture.Changes in bone mineral density and bone turnover in patients on 'drug holiday' following bisphosphonate therapy: real-life clinic setting.FRAX fracture risk in women with a recent fracture of the distal forearm: agreement between assessments with and without bone mineral density and impact of measurement side in the individual patient.Outcomes of applying the NOF, NOGG and Taiwanese guidelines to a cohort of Chinese early postmenopausal women.Application of the fracture risk assessment tool (FRAX(®)) and determination of suitable cut-off values during primary screening in specific health check-ups in Japan.The combination of FRAX and Ageing Male Symptoms scale better identifies treated HIV males at risk for major fracture.[Current prevention and treatment strategies for osteoporosis. Fracture-oriented, effective, low side effects and inexpensive].Metabolomic profiles associated with bone mineral density in US Caucasian womenCorrelations between bone turnover markers, serum magnesium and bone mass density in postmenopausal osteoporosis
P2860
Q26748699-0E087294-9E32-44DA-872F-CA08C2022E8AQ28742150-35949572-EBEE-428F-BA77-3808004FEDF0Q33650243-9A0498F7-A98C-4903-B675-FCD8D44C0D2CQ33792517-A64C0E1A-15E4-4CA9-A574-B1BB94030AF6Q34612526-5E43DA54-7CF8-4FF5-8AAF-B9803324D423Q34680523-611444E5-F7AD-4DAD-AA88-41A88B4A2775Q35039567-55EA3E5C-1BEC-4E30-9D1D-BFF59A9969A1Q35687804-519509A4-E1B3-4AD0-9B91-6C12D830B6C8Q36065361-21FFD2C1-3747-4539-9F88-97D6AE750F79Q36153183-51722395-E900-45DF-9342-33E45EAE3B64Q36701053-112DE271-7797-40C7-8F70-4F3689675D3BQ37135281-E73FF437-C93C-4738-A204-454B4078245EQ37732181-2D00EDA3-28EF-4A87-8AA5-FC6337D6FAC9Q38017952-830A49B4-A2EC-4F64-A6DA-DFACEDA38C98Q38077557-CBBFCA9F-A6B9-4CCF-8DE4-67A1201D16FEQ38125618-EA451A03-EBA8-4B5D-A216-11AF1353870DQ38585164-B277D5C8-AB98-40F7-877E-8AA2DD4A09BAQ40160557-F8964F2B-5973-475B-BCF1-32B707FF4E02Q44011478-810AA96D-1D82-4547-BA0A-42BB21D2A606Q46622441-BA041018-7A0C-4711-B93D-C59838F6B715Q46948852-5D86414A-ECAE-40A7-9F51-3EA6E4E2FB46Q51363659-00635AC8-80BB-4E3F-B2DC-46299588391CQ53664984-462071B2-5527-4797-B78F-758C4ACA8B42Q57112162-F3C3D637-87DF-4CB9-B29E-B6A0DB7F1205Q58802211-A52FCE5A-C850-495E-8739-6213E6861BE8
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
The utility and limitations of FRAX: A US perspective.
@ast
The utility and limitations of FRAX: A US perspective.
@en
The utility and limitations of FRAX: A US perspective.
@nl
type
label
The utility and limitations of FRAX: A US perspective.
@ast
The utility and limitations of FRAX: A US perspective.
@en
The utility and limitations of FRAX: A US perspective.
@nl
prefLabel
The utility and limitations of FRAX: A US perspective.
@ast
The utility and limitations of FRAX: A US perspective.
@en
The utility and limitations of FRAX: A US perspective.
@nl
P2860
P1476
The utility and limitations of FRAX: A US perspective.
@en
P2093
Andrew D Calderon
Stuart L Silverman
P2860
P2888
P304
P356
10.1007/S11914-010-0032-1
P577
2010-12-01T00:00:00Z
P5875
P6179
1048373087